Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.

Grant Approval Process

Grant Approval Process

The Cure Starts Now has funded $29,679,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 196 grants at over 100 hospitals in 29 countries.






Cincinnati Children’s Hospital Medical Center - $170,953

Amount
$170,953.00 USD
Date
October 2024

Combining FLASH and immunotherapy to target medulloblastoma relapse

Grant Information

Emory University / Cincinnati Children's Hospital – $92,831

Amount
$92,831.00 USD
Date
March 2024

SUMOylation as a novel therapeutic target in DIPG

Grant Information

University of Chicago Medical Center / Washington University St. Louis – $100,000

Amount
$100,000.00 USD
Date
December 2023

Characterizing and Targeting ABL1 and ABL2 in Medulloblastoma Leptomeningeal Dissemination.

Grant Information

Icahn School of Medicine at Mount Sinai – $100,000

Amount
$100,000.00 USD
Date
December 2023

Targeting macrophages to improve the survival of DIPG

Grant Information

Children’s Cancer Institute – $50,000 USD / $73,942 AUD (Approx)

Amount
$50,000.00 USD
Date
December 2023

A novel formulation to allow the simultaneous targeting of MYCN expression and copper chelation to treat DIPG tumour and overcome multidrug resistance.

Grant Information

Children’s Hospital Colorado – $98,551

Amount
$98,551.00 USD
Date
December 2023

Dual targeting processive transcription for Myc-driven circuitry in medulloblastoma.

Grant Information

University of Newcastle – $116,997 USD / $173,016 AUD

Amount
$116,997.00 USD
Date
December 2023

(2023) Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies.

Grant Information

Princess Máxima Center for Pediatric Oncology – $98,306

Amount
$98,306.00 USD
Date
December 2023

Assessing the potential of the HDAC inhibitor givinostat ± radiotherapy for the treatment of diffuse midline glioma.

Grant Information

Nemours Children’s Hospital - $49,885

Amount
$49,885.00 USD
Date
December 2023

Treatment of Diffuse Intrinsic Pontine Glioma with the Oncolytic Zika Virus.

Grant Information

Icahn School of Medicine at Mount Sinai - $100,000

Amount
$100,000.00 USD
Date
December 2023

Preclinical evaluation of TP-0184 in an autochthonous mouse model of DIPG/DMG

Grant Information

The University of Alabama at Birmingham – $100,000

Amount
$100,000.00 USD
Date
December 2023

Intranasal Delivery of Targeting Nanotherapeutics for DIPG

Grant Information

Funding of PBTCF 2023 - $25,000

Amount
$25,000.00 USD
Date
December 2023

Children's Cancer Institute – $181,736 USD / $281,691 AUD

Amount
$181,736.00 USD
Date
November 2023

Targeting post-translational protein modification to halt Diffuse Intrinsic Pontine Glioma tumorgenicity

Grant Information

Memorial Sloan Kettering Cancer Center – $100,000

Amount
$100,000.00 USD
Date
November 2023

CSF Cell-free Tumor DNA (CSF cfDNA) Liquid Biopsies for Pediatric, Adolescent, and Young Adult Patients with Primary Brain Tumors

Grant Information

University of Colorado Denver – $198,255

Amount
$198,255.00 USD
Date
November 2023

Preclinical assessment of efficacy and specificity of logic-gated CAR-T cell therapy in Diffuse Intrinsic Pontine Glioma

Grant Information